Arbutus Biopharma Corp Investment Income, Interest
Arbutus Biopharma Corp (ABUS) reported Investment Income, Interest of $842.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-12
CAD
| Period end | Investment Income, Interest 12 month |
|---|---|
| 2012-12-31 | 138.23K CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 124.85K CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 106.96K CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | 163.70K CAD 20-F · filed 2012-03-27 |
USD
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $842.00K 10-Q · filed 2026-08-12 | $1.66M 10-Q · filed 2026-08-12 | $2.53M derived: sum of 3 quarters · filed 2026-08-12 | $3.49M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $815.00K 10-Q · filed 2026-05-13 | $1.69M derived: sum of 2 quarters · filed 2026-05-13 | $2.64M derived: sum of 3 quarters · filed 2026-05-13 | $3.69M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $877.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.83M derived: sum of 2 quarters · filed 2026-03-23 | $2.87M derived: sum of 3 quarters · filed 2026-08-12 | $4.07M 10-K · filed 2026-03-23 | |
| 2025-09-30 | $952.00K 10-Q · filed 2025-11-13 | $1.99M derived: sum of 2 quarters · filed 2026-08-12 | $3.19M 10-Q · filed 2025-11-13 | $4.66M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $1.04M 10-Q · filed 2026-08-12 | $2.24M 10-Q · filed 2026-08-12 | $3.70M derived: sum of 3 quarters · filed 2026-08-12 | $5.45M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-13 | $2.66M derived: sum of 2 quarters · filed 2026-05-13 | $4.41M derived: sum of 3 quarters · filed 2026-05-13 | $6.24M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $3.21M derived: sum of 2 quarters · filed 2026-03-23 | $5.04M derived: sum of 3 quarters · filed 2026-03-23 | $6.58M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $1.75M 10-Q · filed 2025-11-13 | $3.58M derived: sum of 2 quarters · filed 2025-11-13 | $5.12M 10-Q · filed 2025-11-13 | $6.59M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $1.83M 10-Q · filed 2025-08-06 | $3.37M 10-Q · filed 2025-08-06 | $4.84M derived: sum of 3 quarters · filed 2025-08-06 | $6.33M derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | $1.54M 10-Q · filed 2025-05-14 | $3.01M derived: sum of 2 quarters · filed 2025-05-14 | $4.50M derived: sum of 3 quarters · filed 2025-05-14 | $5.96M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.96M derived: sum of 2 quarters · filed 2025-03-27 | $4.42M derived: sum of 3 quarters · filed 2025-03-27 | $5.69M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $1.49M 10-Q · filed 2024-11-06 | $2.96M derived: sum of 2 quarters · filed 2024-11-06 | $4.22M 10-Q · filed 2024-11-06 | $5.17M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $1.46M 10-Q · filed 2024-08-08 | $2.73M 10-Q · filed 2024-08-08 | $3.67M derived: sum of 3 quarters · filed 2024-08-08 | $4.37M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $1.27M 10-Q · filed 2024-05-02 | $2.21M derived: sum of 2 quarters · filed 2024-05-02 | $2.90M derived: sum of 3 quarters · filed 2024-05-02 | $3.30M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | $943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.64M derived: sum of 2 quarters · filed 2024-03-05 | $2.03M derived: sum of 3 quarters · filed 2024-03-05 | $2.19M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $694.00K 10-Q · filed 2023-11-07 | $1.09M derived: sum of 2 quarters · filed 2023-11-07 | $1.25M 10-Q · filed 2023-11-07 | $1.28M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $396.00K 10-Q · filed 2023-08-03 | $555.00K 10-Q · filed 2023-08-03 | $585.00K derived: sum of 3 quarters · filed 2023-08-03 | $612.00K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $159.00K 10-Q · filed 2023-05-04 | $189.00K derived: sum of 2 quarters · filed 2023-05-04 | $216.00K derived: sum of 3 quarters · filed 2023-05-04 | $247.00K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $57.00K derived: sum of 2 quarters · filed 2023-03-02 | $88.00K derived: sum of 3 quarters · filed 2023-03-02 | $127.00K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $27.00K 10-Q · filed 2022-11-09 | $58.00K derived: sum of 2 quarters · filed 2022-11-09 | $97.00K 10-Q · filed 2022-11-09 | $193.00K derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $31.00K 10-Q · filed 2022-08-04 | $70.00K 10-Q · filed 2022-08-04 | $166.00K derived: sum of 3 quarters · filed 2022-08-04 | $266.00K derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | $39.00K 10-Q · filed 2022-05-05 | $135.00K derived: sum of 2 quarters · filed 2022-05-05 | $235.00K derived: sum of 3 quarters · filed 2022-05-05 | $435.00K derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $196.00K derived: sum of 2 quarters · filed 2022-03-03 | $396.00K derived: sum of 3 quarters · filed 2022-03-03 | $741.00K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-04 | $300.00K derived: sum of 2 quarters · filed 2021-11-04 | $645.00K 10-Q · filed 2021-11-04 | $1.05M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | $200.00K 10-Q · filed 2021-08-05 | $545.00K 10-Q · filed 2021-08-05 | $947.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.45M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $345.00K 10-Q · filed 2021-05-05 | $747.00K derived: sum of 2 quarters · filed 2021-05-05 | $1.25M derived: sum of 3 quarters · filed 2021-05-05 | $1.86M derived: sum of 4 quarters · filed 2021-05-05 | |
| 2019-12-31 | $402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $905.00K derived: sum of 2 quarters · filed 2021-03-04 | $1.51M derived: sum of 3 quarters · filed 2021-03-04 | $2.11M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $503.00K 10-Q · filed 2020-11-05 | $1.11M derived: sum of 2 quarters · filed 2020-11-05 | $1.71M 10-Q · filed 2020-11-05 | $2.44M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $606.00K 10-Q · filed 2020-08-07 | $1.21M 10-Q · filed 2020-08-07 | $1.93M derived: sum of 3 quarters · filed 2020-08-07 | $2.69M derived: sum of 4 quarters · filed 2020-08-07 | |
| 2019-03-31 | $600.00K 10-Q · filed 2020-05-11 | $1.33M derived: sum of 2 quarters · filed 2020-05-11 | $2.08M derived: sum of 3 quarters · filed 2020-05-11 | $2.89M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $728.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $1.48M derived: sum of 2 quarters · filed 2020-03-05 | $2.29M derived: sum of 3 quarters · filed 2020-03-05 | $3.05M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $756.00K 10-Q · filed 2019-11-06 | $1.56M derived: sum of 2 quarters · filed 2019-11-06 | $2.32M 10-Q · filed 2019-11-06 | $2.76M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | $805.00K 10-Q · filed 2019-08-05 | $1.56M 10-Q · filed 2019-08-05 | $2.01M derived: sum of 3 quarters · filed 2019-08-05 | $2.34M derived: sum of 4 quarters · filed 2019-08-05 | |
| 2018-03-31 | $758.00K 10-Q · filed 2019-05-06 | $1.20M derived: sum of 2 quarters · filed 2019-05-06 | $1.54M derived: sum of 3 quarters · filed 2019-05-06 | $1.93M derived: sum of 4 quarters · filed 2019-05-06 | |
| 2017-12-31 | $443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $780.00K derived: sum of 2 quarters · filed 2019-03-07 | $1.17M derived: sum of 3 quarters · filed 2019-03-07 | $1.54M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $337.00K 10-Q · filed 2018-11-07 | $727.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.09M 10-Q · filed 2018-11-07 | $1.38M derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | $390.00K 10-Q · filed 2018-08-03 | $758.00K 10-Q · filed 2018-08-03 | $1.04M derived: sum of 3 quarters · filed 2018-08-03 | $1.47M derived: sum of 4 quarters · filed 2018-08-03 | |
| 2017-03-31 | $368.00K 10-Q · filed 2018-05-04 | $655.00K derived: sum of 2 quarters · filed 2018-05-04 | $1.08M derived: sum of 3 quarters · filed 2018-05-04 | $1.51M derived: sum of 4 quarters · filed 2018-05-04 | |
| 2016-12-31 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $712.00K derived: sum of 2 quarters · filed 2018-03-16 | $1.15M derived: sum of 3 quarters · filed 2018-03-16 | $1.39M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $425.00K 10-Q · filed 2017-11-02 | $860.00K derived: sum of 2 quarters · filed 2017-11-02 | $1.10M 10-Q · filed 2017-11-02 | $1.31M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | $435.00K 10-Q · filed 2017-08-03 | $679.00K 10-Q · filed 2017-08-03 | $887.00K derived: sum of 3 quarters · filed 2018-03-16 | $1.07M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | $244.00K 10-Q · filed 2017-05-04 | $452.00K derived: sum of 2 quarters · filed 2018-03-16 | $635.00K derived: sum of 3 quarters · filed 2018-03-16 | $716.00K derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $391.00K derived: sum of 2 quarters · filed 2018-03-16 | $472.00K derived: sum of 3 quarters · filed 2018-03-16 | $674.00K 10-K · filed 2018-03-16 | |
| 2015-09-30 | $183.00K 10-Q · filed 2016-11-03 | $264.00K derived: sum of 2 quarters · filed 2016-11-03 | $466.00K 10-Q · filed 2016-11-03 | $611.00K derived: sum of 4 quarters · filed 2017-03-22 | |
| 2015-06-30 | $81.00K 10-Q · filed 2016-08-04 | $283.00K 10-Q · filed 2016-08-04 | $428.00K derived: sum of 3 quarters · filed 2017-03-22 | $732.00K derived: sum of 4 quarters · filed 2017-03-22 | |
| 2015-03-31 | $202.00K 10-Q · filed 2016-05-04 | $347.00K derived: sum of 2 quarters · filed 2017-03-22 | $651.00K derived: sum of 3 quarters · filed 2017-03-22 | $908.00K derived: sum of 4 quarters · filed 2017-03-22 | |
| 2014-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $449.00K derived: sum of 2 quarters · filed 2017-03-22 | $706.00K derived: sum of 3 quarters · filed 2017-03-22 | $853.00K 10-K · filed 2017-03-22 | |
| 2014-09-30 | $304.00K 10-Q · filed 2015-11-05 | $561.00K derived: sum of 2 quarters · filed 2015-11-05 | $708.00K 10-Q · filed 2015-11-05 | $829.00K derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-06-30 | $257.00K 10-Q · filed 2015-08-07 | $404.00K 10-Q · filed 2015-08-07 | $525.00K derived: sum of 3 quarters · filed 2016-03-09 | $654.00K derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-03-31 | $147.00K 10-Q · filed 2015-05-06 | $268.00K derived: sum of 2 quarters · filed 2016-03-09 | $397.00K derived: sum of 3 quarters · filed 2016-03-09 | $543.00K derived: sum of 4 quarters · filed 2016-03-09 | |
| 2013-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $250.00K derived: sum of 2 quarters · filed 2016-03-09 | $396.00K derived: sum of 3 quarters · filed 2016-03-09 | $540.00K 10-K · filed 2016-03-09 | $540.00K 6-K · filed 2014-03-06 |
| 2013-09-30 | $129.00K 10-Q · filed 2014-11-07 | $275.00K derived: sum of 2 quarters · filed 2014-11-07 | $419.00K 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $146.00K 10-Q · filed 2014-08-14 | $290.00K 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $145.00K 10-Q · filed 2014-05-14 | ||||
| 2012-12-31 | $138.00K 10-K · filed 2015-03-13 | $138.32K 6-K · filed 2014-03-06 | |||
| 2011-12-31 | $126.31K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |